Literature DB >> 1680208

IgA nephropathy in blacks: studies of IgA2 allotypes and clinical course.

P A Crowley-Nowick1, B A Julian, R J Wyatt, J H Galla, B M Wall, D G Warnock, J Mestecky, S Jackson.   

Abstract

The prevalence of IgA nephropathy (IgAN) varies among racial groups, being most common among Caucasians and Orientals and rare in Blacks. Other investigators have hypothesized that the risk for IgAN may be influenced by the IgA2 allotype. It has been suggested that the rare Black patients with IgAN may be homozygous for the A2m(1) allele which predominates in Whites, but is less common in Blacks. In a multicenter study, 27 Black IgAN patients were enrolled to investigate this hypothesis and analyze the clinical course of disease in Blacks. The IgA2 allotypes of 18 Black patients and 14 controls were determined using restriction fragment length polymorphism analysis. Three patients were homozygous for the A2m(1) allele, four were homozygous for A2m(2) and 11 were heterozygous. The respective allelic frequencies of A2m(1) and A2m(2) were 0.47 and 0.53 and did not differ significantly from Black controls. Most clinical manifestations of disease did not significantly differ with respect to distribution of the two alleles, although the gender ratio differed between the homozygous A2m(1) and heterozygous patients. The presence of the A2m(1) allele did not increase the risk for IgAN, and the presence of the A2m(2) allele or homozygosity for this allele did not protect Blacks from the development of IgAN.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1680208     DOI: 10.1038/ki.1991.154

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  6 in total

1.  Demographic and clinical characteristics of primary glomerular diseases in Turkey.

Authors:  Savas Ozturk; Abdullah Sumnu; Nurhan Seyahi; Mustafa Gullulu; Murat Sipahioglu; Serra Artan; Zerrin Bicik; Sim Kutlay; Mustafa Keles; Deren Oygar; Ali Riza Odabas; Mansur Kayatas; Belda Dursun; Hayriye Sayarlioglu; Sinan Trablus; Dilek Guven Taymez; Ali Abbas Ozdemir; Gulizar Manga Sahin; Bulent Altun; Alper Azak; Lutfullah Altintepe; Gultekin Suleymanlar; Mehmet Koc; Yilmaz Selcuk; Rumeyza Kazancioglu; Reha Erkoc; Meltem Gursu; Mehmet Kucuk; Selma Alagoz Akcaoglu; Abdulmecid Yıldız; Aydin Unal; Ozger Akarsu; Kenan Ates; Erdem Cankaya; Aydin Turkmen
Journal:  Int Urol Nephrol       Date:  2014-09-30       Impact factor: 2.370

2.  IgA nephropathy in African Americans: uncommon but possible.

Authors:  Abhilash Koratala; William L Clapp; Don H Esprit; Jogiraju Tantravahi
Journal:  JRSM Open       Date:  2018-06-08

3.  Patterns of biopsy-proven renal disease in people living with HIV: 10 years experience in Sydney, Australia.

Authors:  Dane Turner; Doug Drak; David Gracey; Lyndal Anderson
Journal:  BMC Nephrol       Date:  2022-04-18       Impact factor: 2.585

4.  Great prognosis of concurrent anti-GBM disease and IgA nephropathy in a young woman: A case report.

Authors:  Fu Shaojie; Su Sensen; Huang Jingda; Wang Luyu; Zhang Fei; Yu Jinyu; Xu Zhonggao; Wu Hao
Journal:  Medicine (Baltimore)       Date:  2022-09-16       Impact factor: 1.817

5.  Race/ethnicity and disease severity in IgA nephropathy.

Authors:  Yoshio N Hall; Eloisa F Fuentes; Glenn M Chertow; Jean L Olson
Journal:  BMC Nephrol       Date:  2004-09-02       Impact factor: 2.388

6.  Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy.

Authors:  Katerina Zachova; Petr Kosztyu; Josef Zadrazil; Karel Matousovic; Karel Vondrak; Petr Hubacek; Bruce A Julian; Zina Moldoveanu; Zdenek Novak; Klara Kostovcikova; Milan Raska; Jiri Mestecky
Journal:  Front Immunol       Date:  2020-02-28       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.